Showing 651-660 of 1690 results for "".
Functional Weakness and Dysarthria in a 66-Year-Old Man Previously Diagnosed with CIDP
https://practicalneurology.com/diseases-diagnoses/headache-pain/functional-weakness-and-dysarthria-in-a-66-year-old-man-previously-diagnosed-with-cidp/30353/Reversible and Benign Lesions of Splenium of The Corpus Collosum
https://practicalneurology.com/diseases-diagnoses/imaging-testing/reversible-and-benign-lesions-of-splenium-of-the-corpus-collosum/30269/Aggressive diagnostic and therapeutic approaches are often unnecessary.Comprehensive Stroke Certification What Does Does it Take?
https://practicalneurology.com/diseases-diagnoses/stroke/comprehensive-stroke-certification-what-does-does-it-take/30704/The Ochsner Medical Center ExperienceA Survey of Neurologists on Career Satisfaction and Burnout
https://practicalneurology.com/columns/practice-management/a-survey-of-neurologists-on-career-satisfaction-and-burnout/30707/Movement Disorders in Antiphospholipid Syndrome & Systemic Lupus Erythematosus
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-in-antiphospholipid-syndrome-systemic-lupus-erythematosus/31706/Several movement disorders are seen with APS and SLE, most commonly chorea.Anti-N-Methyl D Aspartate Receptor Encephalitis
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/anti-n-methyl-d-aspartate-receptor-encephalitis/31705/Encephalitis caused by antibodies to the N-methyl-D-aspartate receptor causes symptoms of movement disorders, seizure, and psychiatric disturbances.Genetic Testing & Neuromuscular Disorders
https://practicalneurology.com/diseases-diagnoses/neuromuscular/genetic-testing-neuromuscular-disorders/31920/The cost of genetic testing has decreased significantly, and the results are priceless.Addressing Lifestyle Factors in Poststroke Care
https://practicalneurology.com/diseases-diagnoses/stroke/addressing-lifestyle-factors-in-poststroke-care/31963/Improved nutritional status can improve vascular risk factors, prevent recurrent stroke, and optimize poststroke outcomes.Novel Lipid-Lowering Agents and Stroke Prevention:
New Tools, New Targetshttps://practicalneurology.com/diseases-diagnoses/stroke/novel-lipid-lowering-agents-and-stroke-preventionbrnew-tools-new-targets/32074/Established and novel lipid-lowering agents offer increasing opportunities to achieve effective primary and secondary stroke prevention.Lipid Management & Smoking Cessation
https://practicalneurology.com/diseases-diagnoses/stroke/lipid-management-smoking-cessation/31863/High cholesterol and smoking are modifiable factors to prevent secondary stroke.